SG148183A1 - Succinate and malonate salt of trans-4-(1r,3s)-6-chloro-3-phenylindan-1-yl)- 1,2,2-trimethylpiperazine and the use as a medicament - Google Patents

Succinate and malonate salt of trans-4-(1r,3s)-6-chloro-3-phenylindan-1-yl)- 1,2,2-trimethylpiperazine and the use as a medicament

Info

Publication number
SG148183A1
SG148183A1 SG200808521-9A SG2008085219A SG148183A1 SG 148183 A1 SG148183 A1 SG 148183A1 SG 2008085219 A SG2008085219 A SG 2008085219A SG 148183 A1 SG148183 A1 SG 148183A1
Authority
SG
Singapore
Prior art keywords
phenylindan
trimethylpiperazine
succinate
trans
medicament
Prior art date
Application number
SG200808521-9A
Inventor
De Diego Heidi Lopez
Ole Nielsen
Lone Munch Ringgard
Henrik Svane
Allan Carsten Dahl
Mark Howells
Benny Bang-Andersen
Lars Ole Lyngsi
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of SG148183A1 publication Critical patent/SG148183A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/18—Polycyclic aromatic halogenated hydrocarbons
    • C07C25/22—Polycyclic aromatic halogenated hydrocarbons with condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SUCCINATE AND MALONATE SALT OF TRANS-4-(1R,3S)-6-CHLORO-3-PHENYLINDAN-1-YL)- 1,2,2-TRIMETHYLPIPERAZINE AND THE USE AS A MEDICAMENT
SG200808521-9A 2003-08-18 2004-08-18 Succinate and malonate salt of trans-4-(1r,3s)-6-chloro-3-phenylindan-1-yl)- 1,2,2-trimethylpiperazine and the use as a medicament SG148183A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200301180 2003-08-18
DKPA200301305 2003-09-11

Publications (1)

Publication Number Publication Date
SG148183A1 true SG148183A1 (en) 2008-12-31

Family

ID=58707237

Family Applications (2)

Application Number Title Priority Date Filing Date
SG200808521-9A SG148183A1 (en) 2003-08-18 2004-08-18 Succinate and malonate salt of trans-4-(1r,3s)-6-chloro-3-phenylindan-1-yl)- 1,2,2-trimethylpiperazine and the use as a medicament
SG200805893-5A SG145723A1 (en) 2003-08-18 2004-08-18 Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG200805893-5A SG145723A1 (en) 2003-08-18 2004-08-18 Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine

Country Status (16)

Country Link
KR (2) KR101227789B1 (en)
CN (1) CN101935305B (en)
AR (2) AR045278A1 (en)
AT (1) ATE552247T1 (en)
DK (1) DK1658277T3 (en)
EA (2) EA014641B1 (en)
ES (1) ES2383369T3 (en)
HK (2) HK1096089A1 (en)
IS (1) IS8264A (en)
ME (1) MEP2408A (en)
MY (2) MY154535A (en)
PT (1) PT1658277E (en)
RS (3) RS20060083A (en)
SG (2) SG148183A1 (en)
SI (1) SI1658277T1 (en)
TW (2) TWI403505B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI453198B (en) * 2005-02-16 2014-09-21 Lundbeck & Co As H Process for making the trans-1-( (1r , 3s)- 6-chloro - 3 -phenylindan-1- yl ) - 3 , 3 - dimethylpiperazine and salts thereof and for making 4 -((1r , 3s )-6- chloro- 3- phenylindan -1- yl )-1, 2 , 2 -trimethylpiperazine and salts thereof
PL2720989T3 (en) 2011-06-20 2017-05-31 H. Lundbeck A/S Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE50867B1 (en) * 1980-02-29 1986-08-06 Kefalas As Indane derivatives
DK55192D0 (en) * 1992-04-28 1992-04-28 Lundbeck & Co As H 1-piperazino-1,2-dihydroindene derivatives

Also Published As

Publication number Publication date
EA014641B1 (en) 2010-12-30
ATE552247T1 (en) 2012-04-15
HK1096089A1 (en) 2007-05-25
MY154535A (en) 2015-06-30
AR045278A1 (en) 2005-10-19
KR101227789B1 (en) 2013-01-30
IS8264A (en) 2006-01-26
SI1658277T1 (en) 2012-10-30
CN101935305A (en) 2011-01-05
KR20060066094A (en) 2006-06-15
RS20060121A (en) 2008-09-29
ES2383369T3 (en) 2012-06-20
AR045279A1 (en) 2005-10-19
RS20060083A (en) 2008-08-07
MY149089A (en) 2013-07-15
TWI403505B (en) 2013-08-01
TW201111351A (en) 2011-04-01
HK1152699A1 (en) 2012-03-09
EA200600443A1 (en) 2006-08-25
TW200519098A (en) 2005-06-16
DK1658277T3 (en) 2012-06-18
KR20060066104A (en) 2006-06-15
PT1658277E (en) 2012-05-25
MEP2408A (en) 2010-02-10
RS53369B (en) 2014-10-31
CN101935305B (en) 2013-04-10
SG145723A1 (en) 2008-09-29
EA200600441A1 (en) 2006-08-25
TWI388550B (en) 2013-03-11

Similar Documents

Publication Publication Date Title
IL173788A0 (en) Succinate and malonate salt of trans-4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
AU2003301815A1 (en) Hypodermic needle
AU2003293757A1 (en) Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments
AU2003241327A1 (en) Amidinylphenyl compounds and their use as fungicides
IL173204A0 (en) Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments
AU2003247137A1 (en) Syringe pump
AU2003215209A1 (en) Syringe
AU2003216934A1 (en) Benzoxazinone derivatives, the preparation and use thereof as medicaments
AU2003279442A1 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
AU2003292263A1 (en) Use of substituted 2-phenylbenzimidazoles as medicaments
AU2003259457A1 (en) Auto-destructible syringe
AU2003277556A1 (en) Syringe pump
PT1638943E (en) Novel imidazole derivatives, the production thereof, and the use of the same as a medicament
AU2003274351A1 (en) Substituted pyridyloxyalkylamides and their use as fungicides
PL375627A1 (en) 2-pyrrolidin-2-yl-[1,3,4]-oxadiazole derivatives and the use of the same as antidepressants
SG148183A1 (en) Succinate and malonate salt of trans-4-(1r,3s)-6-chloro-3-phenylindan-1-yl)- 1,2,2-trimethylpiperazine and the use as a medicament
AU2003217942A1 (en) Modulators of leukocyte activation, compositions, and methods of use
AU2003232785A1 (en) Novel anthracene derivatives and the use thereof as a medicament
AU2003296545A1 (en) Use of a trpm8-activating substance for the treatment of tumours
AU2002335304A1 (en) The use of berberine as insulin sensitizer
AU2003255727A1 (en) Syringes
AU2003294952A1 (en) 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same
MY137953A (en) New association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent